Shire’s Buy Rating Reaffirmed at Jefferies Group (SHP)
Shares of Shire opened at 2079.00 on Wednesday. Shire has a 52 week low of GBX 1682.00 and a 52 week high of GBX 2270.00. The stock’s 50-day moving average is currently GBX 1877.. The company’s market cap is £11.472 billion.
A number of other analysts have also recently weighed in on SHP. Analysts at Deutsche Bank raised their price target on shares of Shire from $35.31 to $36.09 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at JPMorgan Chase reiterated an “overweight” rating on shares of Shire in a research note to investors on Tuesday. They now have a $36.32 price target on the stock. Finally, analysts at UBS AG raised their price target on shares of Shire from $34.71 to $37.19 in a research note to investors on Friday, February 15th. They now have a “buy” rating on the stock.
Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.